Understanding Your Laurence-Moon Syndrome Diagnosis
At a Glance
Laurence-Moon syndrome is a rare PNPLA6-related genetic condition distinct from Bardet-Biedl syndrome. It can affect the eyes, balance and muscle control, and pituitary hormones, so care often involves neurological, eye, endocrine, and genetic assessment.
Receiving a diagnosis of Laurence-Moon syndrome can feel like entering a maze of confusing medical terms. It is completely normal to feel overwhelmed, especially if you have spent years searching for answers. You may have found older documents or websites that group this condition with another, called Bardet-Biedl syndrome (BBS) [1]. For many years, doctors used these names interchangeably or used the combined name “Laurence-Moon-Bardet-Biedl syndrome” (LMBBS) [2].
Modern genetics has changed this. We now know that while they share some historical roots and a few similar features, they are caused by different genetic variants and affect the body in distinct ways [3]. Understanding that your diagnosis is specifically related to the PNPLA6 gene is the first step in moving from confusion toward a clear management plan [3].
Clearing the Naming Confusion
Historically, doctors grouped these conditions together because both can involve vision loss and hormonal issues. However, researchers have now identified that Laurence-Moon syndrome is specifically linked to pathogenic variants in the PNPLA6 gene [3].
Unlike Bardet-Biedl syndrome, which is caused by problems in the cilia (the tiny, hair-like sensory structures on cells), Laurence-Moon syndrome involves reduced or abnormal function of an enzyme called neuropathy target esterase (NTE) [1]. This enzyme is essential for maintaining the health of your nervous system [3].
Because of this genetic difference, certain symptoms often found in BBS are less typical or not usually reported in Laurence-Moon syndrome [1][4]. These include:
- Polydactyly: Extra fingers or toes are a hallmark of BBS but are not typically part of the PNPLA6 spectrum.
- Early-Onset Obesity: While weight management is a major challenge in BBS, it is not a defining feature of Laurence-Moon syndrome.
- Severe Kidney Disease: Kidney abnormalities are common in BBS but are generally not a primary feature of PNPLA6-related cases.
Note: While these features are not typical for Laurence-Moon syndrome, any unexpected symptoms you experience should still be evaluated by your doctor.
How PNPLA6 Affects the Body
The PNPLA6 gene is associated with a broad spectrum of neurological and hormonal conditions. Your doctors may use terms like Boucher-Neuhäuser syndrome or Gordon Holmes syndrome because they overlap significantly with Laurence-Moon; they are all different presentations of the same genetic condition [5][6].
The core systems commonly affected include:
The Eyes (Chorioretinal Dystrophy)
A common early sign is chorioretinal dystrophy, a progressive breakdown of the layers at the back of the eye [7]. This often begins with night blindness or a loss of peripheral (side) vision. In some people, eye symptoms are the only sign of the condition for many years before other symptoms appear [7].
The Brain and Nerves (Ataxia and Spasticity)
Because the NTE enzyme is vital to nerve health, the nervous system is often affected:
- Ataxia: This refers to a lack of coordination or balance, often caused by changes in the cerebellum (the part of the brain that controls movement) [8].
- Spastic Paraplegia: This is a stiffness or “tightness” in the leg muscles that can make walking difficult [5].
The Endocrine System (Hypogonadotropic Hypogonadism)
The pituitary gland, which acts as the body’s master control for hormones, may not signal the body correctly to produce sex hormones [3]. This condition, called hypogonadotropic hypogonadism, can lead to delayed puberty or challenges with fertility. Some individuals may also have a deficiency in growth hormones or other pituitary hormones [9].
Navigating the Emotional Impact
Finding out you have a rare disease with a confusing history is emotionally taxing. You may have been met with outdated information or doctors who are unfamiliar with the specific PNPLA6 connection.
It is normal to feel:
- Vindicated: Finally having a name for what you are experiencing.
- Overwhelmed: Dealing with the “multi-system” nature of the diagnosis, which requires visits to many different specialists (like neurologists, eye doctors, and endocrinologists).
- Isolated: Knowing that very few people—including some medical professionals—truly understand the nuances of Laurence-Moon versus BBS.
Validation comes from knowing that your symptoms have a clear biological cause. By focusing on the PNPLA6 gene, you and your care team can stop looking at general “umbrella” information and start focusing on the specific monitoring and support you need for your eyes, your hormones, and your mobility [10].
Common questions in this guide
What causes Laurence-Moon syndrome?
Is Laurence-Moon syndrome the same as Bardet-Biedl syndrome?
What symptoms can Laurence-Moon syndrome cause?
What does chorioretinal dystrophy mean in Laurence-Moon syndrome?
How can PNPLA6-related disease affect movement and hormones?
Which specialists may help manage Laurence-Moon syndrome?
What should I ask about my PNPLA6 genetic test results?
Get notified when new evidence is published on Laurence-Moon syndrome.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.
References
References (10)
- 1
Prenatal diagnosis of Bardet Biedl Syndrome: A case report.
Arora E, Fuks A, Meyer J, Chervenak J
Radiology case reports 2023; (18(1)):326-330 doi:10.1016/j.radcr.2022.10.040.
PMID: 36406960 - 2
Bardet-Biedl Syndrome With Renal, Cardiac, and Genitourinary Malformations: A Case Report.
Waleed MS, Varughese AA, Amba V, Pathalapati R
Cureus 2021; (13(12)):e20577 doi:10.7759/cureus.20577.
PMID: 35103156 - 3
PNPLA6 disorders: what's in a name?
Liu J, Hufnagel RB
Ophthalmic genetics 2023; (44(6)):530-538 doi:10.1080/13816810.2023.2254830.
PMID: 37732399 - 4
Multifaceted and Age-Dependent Phenotypes Associated With Biallelic PNPLA6 Gene Variants: Eight Novel Cases and Review of the Literature.
Nanetti L, Di Bella D, Magri S, et al.
Frontiers in neurology 2021; (12()):793547 doi:10.3389/fneur.2021.793547.
PMID: 35069422 - 5
Different Cerebellar Ataxia Phenotypes Associated with Mutations of the PNPLA6 Gene in Brazilian Patients with Recessive Ataxias.
Teive HAG, Camargo CHF, Sato MT, et al.
Cerebellum (London, England) 2018; (17(3)):380-385 doi:10.1007/s12311-017-0909-y.
PMID: 29248984 - 6
Novel PNPLA6 Variants: Hypogonadotropic Hypogonadism, Pituitary Hypoplasia, Anosmia, and Cerebellar Atrophy in Siblings.
Hussain MA, Kumar V, Chapla A, et al.
JCEM case reports 2026; (4(1)):luaf286 doi:10.1210/jcemcr/luaf286.
PMID: 41356532 - 7
Novel variants in PNPLA6 causing syndromic retinal dystrophy.
Wu S, Sun Z, Zhu T, et al.
Experimental eye research 2021; (202()):108327 doi:10.1016/j.exer.2020.108327.
PMID: 33141049 - 8
Pure Cerebellar Ataxia with Homozygous Mutations in the PNPLA6 Gene.
Wiethoff S, Bettencourt C, Paudel R, et al.
Cerebellum (London, England) 2017; (16(1)):262-267 doi:10.1007/s12311-016-0769-x.
PMID: 26995604 - 9
New insights into Oliver-McFarlane syndrome: adrenocortical hypofunction and variable expressivity in a Chinese sibling pair.
Du C, Yu T, Liu S, et al.
Journal of pediatric endocrinology & metabolism : JPEM 2026; (39(6)):622-627 doi:10.1515/jpem-2025-0731.
PMID: 41846525 - 10
Neuropathy target esterase activity defines phenotypes among PNPLA6 disorders.
Liu J, He Y, Lwin C, et al.
Brain : a journal of neurology 2024; (147(6)):2085-2097 doi:10.1093/brain/awae055.
PMID: 38735647
This page is for informational purposes only and does not constitute medical advice. Discuss your PNPLA6 test results, symptoms, and monitoring plan with your healthcare team.